PhoenixBio Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	1,598	1,541	1,715	2,124	1,324	1,013
Revenue Growth (YoY)	4.44%	-10.15%	-19.26%	60.42%	30.70%	-22.67%
Cost of Revenue	345	424	521	567	597	425
Gross Profit	1,253	1,117	1,194	1,557	727	588
Selling, General & Admin	892	977	969	836	665	636
Research & Development	273	273	206	205	219	221
Operating Expenses	1,174	1,253	1,189	1,048	895	865
Operating Income	79	-136	5	509	-168	-277
Interest Expense	-5	-5	-2	-3	-	-1
Interest & Investment Income	10	8	5	2	-	1
Currency Exchange Gain (Loss)	1	-25	17	-9	23	20
Other Non Operating Income (Expenses)	5	4	18	11	18	33
EBT Excluding Unusual Items	90	-154	43	510	-127	-224
Gain (Loss) on Sale of Investments	-	-	17	-	-	-
Asset Writedown	-166	-168	-1	-	-265	-
Other Unusual Items	-110	-110	-	-	-	-
Pretax Income	-186	-432	59	510	-392	-224
Income Tax Expense	19	16	33	17	-5	14
Net Income	-205	-448	26	493	-387	-238
Net Income to Common	-205	-448	26	493	-387	-238
Net Income Growth	-	-	-94.73%	-	-	-
Shares Outstanding (Basic)	4	4	4	3	3	3
Shares Outstanding (Diluted)	4	4	4	5	3	3
Shares Change (YoY)	-0.59%	6.95%	-25.42%	53.57%	2.11%	10.34%
EPS (Basic)	-50.78	-110.76	6.88	145.13	-117.20	-73.60
EPS (Diluted)	-50.78	-110.76	6.88	97.29	-117.20	-73.60
EPS Growth	-	-	-92.93%	-	-	-
Free Cash Flow	-	-94	-110	270	10	-282
Free Cash Flow Per Share	-	-23.24	-29.09	53.25	3.03	-87.20
Gross Margin	78.41%	72.48%	69.62%	73.30%	54.91%	58.05%
Operating Margin	4.94%	-8.82%	0.29%	23.96%	-12.69%	-27.35%
Profit Margin	-12.83%	-29.07%	1.52%	23.21%	-29.23%	-23.49%
Free Cash Flow Margin	-	-6.10%	-6.41%	12.71%	0.76%	-27.84%
EBITDA	109.25	-108	30	532	-82	-222
EBITDA Margin	6.84%	-7.01%	1.75%	25.05%	-6.19%	-21.92%
D&A For EBITDA	30.25	28	25	23	86	55
EBIT	79	-136	5	509	-168	-277
EBIT Margin	4.94%	-8.82%	0.29%	23.96%	-12.69%	-27.34%
Effective Tax Rate	-	-	55.93%	3.33%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.